Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages
about
The Vpr protein from HIV-1: distinct roles along the viral life cycleImportin alpha3 interacts with HIV-1 integrase and contributes to HIV-1 nuclear import and replicationComparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients.Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2AEstablishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeletonThe macrophage: a therapeutic target in HIV-1 infectionHIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cellsHuman immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanismNaturally-occurring genetic variants in human DC-SIGN increase HIV-1 capture, cell-transfer and risk of mother-to-child transmissionHuman immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation.The ataxia telangiectasia-mutated and Rad3-related protein is dispensable for retroviral integrationHuman immunodeficiency virus type 1 vpr induces apoptosis through caspase activationActivation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expressionVpr-host interactions during HIV-1 viral life cycle.Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of VPR.Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrestNucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr.The functions of the HIV1 protein Vpr and its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase.HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.Differential effects of Vpr on single-cycle and spreading HIV-1 infections in CD4+ T-cells and dendritic cells.Novel factors interfering with human immunodeficiency virus-type 1 replication in vivo and in vitro.Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr- and gamma irradiation-induced apoptosis.Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA.HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis.HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic interventionEffect on HIV-1 gene expression, Tat-Vpr interaction and cell apoptosis by natural variants of HIV-1 Tat exon 1 and Vpr from Northern IndiaNuclear import of viral DNA genomes.Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localizationThe HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor.Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA.Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis.The phosphorylation of HIV-1 Gag by atypical protein kinase C facilitates viral infectivity by promoting Vpr incorporation into virions.Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.Macrophage signaling in HIV-1 infection.Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.The role of HIV-1 Vpr in promoting the infection of nondividing cells and in cell cycle arrest.Genetic selection of peptide inhibitors of human immunodeficiency virus type 1 Vpr.
P2860
Q21245211-A70C5798-C2F6-45F6-8B6A-8FE88D3E122DQ24322708-FE39EC87-F4B1-4525-998B-758B67260B54Q24538755-B03165E0-E2CA-4FAC-AFF9-902709EB30A4Q24630574-01FA8739-1161-4C65-ADA3-D8260A554FE9Q24647043-033EF3EA-8E1B-4404-8E71-7AFC7071DC06Q26823236-C1DBD90C-DE0D-481E-B976-CB943A31F187Q28208528-486F4651-DE57-49F8-9975-08B1ABC788E7Q28245301-CE758A99-D910-4412-8059-3CB3CD5AB783Q28727311-B8ABEC07-7B3B-44F6-AA64-7E39D0EE5A0BQ33292459-390B8E89-6E2C-4D25-9781-B99A9425A962Q33587139-BD799DF4-D59D-4FF4-B5D8-81DB380EDF66Q33707301-A8CB9678-C069-40C2-84A0-DBC6804C8FD3Q33717181-60EB1B5E-76DE-46AD-B462-9B7688290587Q33801078-87801C51-18CC-4949-B369-12E284F54B9AQ33804558-C5FDAB13-7278-402F-ABFD-A5E09A3F243EQ33828332-71C7A7FF-85AC-4F30-9BFC-1B36FD85936DQ33831542-737F794D-7C7B-4E96-B806-CFBED48666CEQ33834244-8EA756EA-172A-4067-A530-31A5606DC796Q33836817-676B3075-D216-4DA6-BA73-FAB96D34333AQ33891972-6076A4C7-4A60-4459-99F0-620178D403B0Q34087997-C6197F5E-7935-431A-9D91-86BAAEB402DDQ34263217-51B656FC-1E73-44D1-A11C-1651C6E9E79AQ34323296-E66920CB-BE87-4E4E-8948-E9B2C3B31944Q34467563-44BF8EEA-06C0-47CA-9BFA-CC966EBFAE4EQ34782531-4ADE5A63-7EB2-4450-8914-25FE14C36884Q34848256-B591D19B-3345-4B36-93AF-485615DFD305Q34957142-5C87E08B-1857-4877-8A63-11B13C7B014FQ35075250-21E5BBB2-E7AB-4937-888B-8437E078F9EFQ35092065-F4583A4B-E531-4513-8956-42293F09AE40Q35200604-DF05BFCE-021D-4067-8854-94DA3C0F44EBQ35834594-A1B74C67-891B-4521-BD2E-C474070EEAFDQ36099149-3C60F8D4-0339-49E5-95E6-43CF7AE13808Q37063467-4499BAA9-639E-4ECE-8057-C55F8B1E4BC2Q37528045-BB0F80DA-C99D-4AD4-8449-8FA7C584173CQ37583427-62166A4C-A7A5-4A37-BF53-74684F9B35E4Q37600700-4D9A8FBB-155F-4322-BA2E-B4563379E4B8Q37728093-67CBB52D-A64E-41A8-B43B-D58AECD75367Q37950254-F31F9A27-1088-4EBB-A28F-DBB792A67E2CQ37978492-9EB8BF2D-2E67-4E27-94F2-5DF7B4D0DB9AQ38361966-717ABA57-44FA-49A1-9091-7B08B89CE01C
P2860
Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Human immunodeficiency virus t ...... y in primary human macrophages
@ast
Human immunodeficiency virus t ...... y in primary human macrophages
@en
type
label
Human immunodeficiency virus t ...... y in primary human macrophages
@ast
Human immunodeficiency virus t ...... y in primary human macrophages
@en
prefLabel
Human immunodeficiency virus t ...... y in primary human macrophages
@ast
Human immunodeficiency virus t ...... y in primary human macrophages
@en
P2093
P2860
P356
P1476
Human immunodeficiency virus t ...... y in primary human macrophages
@en
P2093
A Kessous-Elbaz
D Bergeron
R A Subbramanian
P2860
P304
P356
10.1084/JEM.187.7.1103
P407
P577
1998-04-01T00:00:00Z